PREPARATIONS PROVIDING RNA-INTERFERENCE FOR GST-PI GENE MODULATION Russian patent published in 2020 - IPC A61K31/713 A61K31/52 

Abstract RU 2719185 C2

FIELD: biotechnology.

SUBSTANCE: described is siRNA for inhibiting expression of GST-π, containing a sense chain and an antisense chain, where the chains form a duplex region, and where the antisense strand is SEQ ID NO: 157, and the sense strand is SEQ ID NO: 131, where the length of each chain is 30 nucleotides or less. Described also is a composition containing said siRNA. Disclosed is a method of treating a disease associated with GST-π expression. Also disclosed is siRNA for inhibiting expression of GST-π, comprising a sense chain and an antisense chain, where the chains form a duplex region, and where the antisense strand is SEQ ID NO: 195, and the sense strand is SEQ ID NO: 183, where length of each chain is 30 nucleotides or less. Disclosed are corresponding pharmaceutical compositions.

EFFECT: invention can be used in methods for preventing or treating a disease, such as a malignant tumor.

65 cl, 14 dwg, 14 tbl, 17 ex

Similar patents RU2719185C2

Title Year Author Number
MIRNA STRUCTURES WITH HIGH ACTIVITY AND REDUCED EXPOSURE OUTSIDE THE TARGET 2016
  • Ying, Wenbin
  • Minomi, Kenjirou
  • Harborth, Jens
  • Cina, Cima
  • Zheng, Jane
  • Vaish, Narendra
RU2788030C2
LIPOSOMS WITH RETYNOID TO STRENGTHEN hsp47 EXPRESSION MODULATION 2012
  • Niitsu Joshiro
  • Pejn Dzhozef I.
  • Knopov Viktor
  • Akopyan Violetta
  • Uitt Richard P.
  • Akhmadian Mukhammed
  • Perelman Loren A.
  • Tanaka Yasunobu
  • Fajnshtajn Elena
  • Avkin-Nakhum Sharon
  • Kalinskij Khagar
  • Mett Igor
  • Minomi Kenzhiro
  • Ing Venbin
  • Liu Yun
RU2628694C2
NOTCH 1-SPECIFIC SIRNA MOLECULES 2014
  • Shrajber Seren
RU2651493C2
COMPOSITIONS BASED ON iRNA SERPINA1 AND THEIR APPLICATION METHODS 2017
  • Shlegel, Mark, K.
  • Dzhanas, Majya
  • Dzhadkhav, Vasant, R.
  • Foster, Donald
  • Manokharan, Mutkhiakh
  • Radzhiv, Kallantkhottatkhil, G.
  • Kel'In, Aleksander, V.
  • Kharisse, Klaus
  • Nair, Dzhayaprakash, K.
  • Majer, Martin, A.
  • Matsuda, Shigeo
  • Dzhayaraman, Mutkhusami
  • Sekhgal, Alfika
  • Braun, Kristofer
  • Fitsdzherald, Kevin
  • Milstejn, Styuart
RU2761667C2
THYMIDILATE SYNTHASE TARGETING RNAI MOLECULE AND USING IT 2010
  • Vada Khiromi
  • Khuan Chehn Lun
RU2535993C2
iRNA-MEDIATED INHIBITION OF TUMOUR NECROSIS FACTOR-( RELATED CONDITIONS 2007
  • Janni Dzhon M.
  • Chatterton Dzhon E.
  • Senchina Dajan Mishell'
  • Gamach Dehniel A.
  • Miller Stiven T.
RU2469090C2
RNA INTERFERENCE MEDIATED INHIBITION OF HEPATITIS B VIRUS (HBV) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) 2011
  • Bartts Stiv
  • Braun Dunkan
  • Robinson Majkl
RU2624045C2
METHODS FOR TREATMENT OF HEPATITIS B INFECTION 2018
  • Koser, Martin
  • Abrams, Marc
RU2780021C2
AGENT INDUCING CELL DEATH FOR CELLS HAVING BRAF GENE MUTATIONS, AGENT SUPPRESSING GROWTH OF SUCH CELLS, AND PHARMACEUTICAL COMPOSITION FOR THE THERAPY OF DISEASES CAUSED BY GROWTH DEFECT OF SUCH CELLS 2016
  • Nishita Hiroki
  • Nisita Khiroki
RU2760835C2
THERAPEUTIC COMPOSITIONS AND METHODS AGAINST MALIGNANT TUMORS WITH RNAi MOLECULES DIRECTED AGAINST Hsp47 2015
  • Minomi, Kenjirou
  • Tamura, Yasuaki
  • Yoneda, Akihiro
  • Liu, Jihua
  • Majeti, Bharat
  • Ying, Wenbin
RU2756253C2

RU 2 719 185 C2

Authors

Terada, Erika

Takahashi, Hirokazu

Minomi, Kenjirou

Ying, Wenbin

Ahmadian, Mohammad

Zhang, Jun

Harborth, Jens

Dates

2020-04-17Published

2015-12-28Filed